816 related articles for article (PubMed ID: 17290064)
1. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
[TBL] [Abstract][Full Text] [Related]
2. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.
Verhoef MJ; Mulkins A; Carlson LE; Hilsden RJ; Kania A
Integr Cancer Ther; 2007 Dec; 6(4):345-53. PubMed ID: 18048882
[TBL] [Abstract][Full Text] [Related]
3. Trusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents.
Daugherty CK; Fitchett G; Murphy PE; Peterman AH; Banik DM; Hlubocky F; Tartaro J
Psychooncology; 2005 Feb; 14(2):135-46. PubMed ID: 15386780
[TBL] [Abstract][Full Text] [Related]
4. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials.
Dy GK; Bekele L; Hanson LJ; Furth A; Mandrekar S; Sloan JA; Adjei AA
J Clin Oncol; 2004 Dec; 22(23):4810-5. PubMed ID: 15570083
[TBL] [Abstract][Full Text] [Related]
5. Use of complementary medicine by adult patients participating in cancer clinical trials.
Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
[TBL] [Abstract][Full Text] [Related]
6. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
Singh H; Maskarinec G; Shumay DM
Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
[TBL] [Abstract][Full Text] [Related]
7. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
Chrystal K; Allan S; Forgeson G; Isaacs R
N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
[TBL] [Abstract][Full Text] [Related]
8. Complementary and alternative medicine use among individuals participating in research: implications for research and practice.
Welder GJ; Wessel TR; Arant CB; Schofield RS; Zineh I
Pharmacotherapy; 2006 Dec; 26(12):1794-801. PubMed ID: 17125440
[TBL] [Abstract][Full Text] [Related]
9. Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication.
Meropol NJ; Weinfurt KP; Burnett CB; Balshem A; Benson AB; Castel L; Corbett S; Diefenbach M; Gaskin D; Li Y; Manne S; Marshall J; Rowland JH; Slater E; Sulmasy DP; Van Echo D; Washington S; Schulman KA
J Clin Oncol; 2003 Jul; 21(13):2589-96. PubMed ID: 12829680
[TBL] [Abstract][Full Text] [Related]
10. Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions.
Elkin EB; Kim SH; Casper ES; Kissane DW; Schrag D
J Clin Oncol; 2007 Nov; 25(33):5275-80. PubMed ID: 18024875
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience.
Naing A; Stephen SK; Frenkel M; Chandhasin C; Hong DS; Lei X; Falchook G; Wheler JJ; Fu S; Kurzrock R
Cancer; 2011 Nov; 117(22):5142-50. PubMed ID: 21538342
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in motives for use of complementary and alternative medicine among cancer patients.
Hedderson MM; Patterson RE; Neuhouser ML; Schwartz SM; Bowen DJ; Standish LJ; Marshall LM
Altern Ther Health Med; 2004; 10(5):58-64. PubMed ID: 15478787
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and complementary and alternative medicine use among cancer patients in Turkey.
Can G; Erol O; Aydiner A; Topuz E
Eur J Oncol Nurs; 2009 Sep; 13(4):287-94. PubMed ID: 19395312
[TBL] [Abstract][Full Text] [Related]
14. The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.
Weinfurt KP; Castel LD; Li Y; Sulmasy DP; Balshem AM; Benson AB; Burnett CB; Gaskin DJ; Marshall JL; Slater EF; Schulman KA; Meropol NJ
Cancer; 2003 Jul; 98(1):166-75. PubMed ID: 12833469
[TBL] [Abstract][Full Text] [Related]
15. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy.
Swarup AB; Barrett W; Jazieh AR
Am J Clin Oncol; 2006 Oct; 29(5):468-73. PubMed ID: 17023781
[TBL] [Abstract][Full Text] [Related]
16. Religious and spiritual resources, CAM, and conventional treatment in the lives of cancer patients.
Tatsumura Y; Maskarinec G; Shumay DM; Kakai H
Altern Ther Health Med; 2003; 9(3):64-71. PubMed ID: 12776477
[TBL] [Abstract][Full Text] [Related]
17. Palliative chemotherapy preferences and factors that influence patient choice in incurable advanced cancer.
Kim MK; Lee JL; Hyun MS; Do YR; Song HS; Kim JG; Bae SH; Ryoo HM; Park KU; Lee KH
Jpn J Clin Oncol; 2008 Jan; 38(1):64-70. PubMed ID: 18238880
[TBL] [Abstract][Full Text] [Related]
18. The influence of significant others in complementary and alternative medicine decisions by cancer patients.
Ohlén J; Balneaves LG; Bottorff JL; Brazier AS
Soc Sci Med; 2006 Sep; 63(6):1625-36. PubMed ID: 16725245
[TBL] [Abstract][Full Text] [Related]
19. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment.
Shumay DM; Maskarinec G; Kakai H; Gotay CC;
J Fam Pract; 2001 Dec; 50(12):1067. PubMed ID: 11742609
[TBL] [Abstract][Full Text] [Related]
20. Veterans' decision-making preferences and perceived involvement in care for chronic heart failure.
Rodriguez KL; Appelt CJ; Switzer GE; Sonel AF; Arnold RM
Heart Lung; 2008; 37(6):440-8. PubMed ID: 18992627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
